Streetbeat News

Price Targets

DRI

Darden Restaurants (NYSE:DRI) has been rated by 12 analysts in the last three months, with a mix of bullish and somewhat bullish perspectives. The average 12-month price target is $172.5, up from $166.25, with a high of $190.00 and a low of $155.00. Analysts from firms like Barclays, Oppenheimer, and Truist Securities have updated their ratings and price targets, reflecting their views on the company's market performance and financial health. Darden Restaurants, a major U.S. full-service restaurant operator, has faced a slight revenue decline of -0.12% over 3 months but maintains strong profitability with a net margin of 7.78% and an ROE of 10.13%, despite a high debt-to-equity ratio of 2.71.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 8:00 pm

SILK

Silk Road Medical (NASDAQ:SILK) has been evaluated by 5 analysts over the last three months, with a shift towards a more bullish stance in the last 30 days. The average 12-month price target has been reduced by 67.3% to $13.00, with a high estimate of $20.00 and a low of $8.00. Analysts from Lake Street, Piper Sandler, Citigroup, B. Riley Securities, and Stifel have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Silk Road Medical specializes in reducing stroke risk with its TCAR procedure and has shown a revenue growth rate of 18.89% as of September 30, 2023.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 8:00 pm

NXT

Mizuho analyst Anthony Crowdell has reaffirmed a Buy rating on NEXTracker (NASDAQ:NXT) and increased the price target from $50 to $56, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:52 pm

GSK

GSK's stock is trading higher following two positive developments: an amendment to the exclusive license agreement with SCYNEXIS and an upgrade from Jefferies from Hold to Buy with an increased price target from $38.5 to $48.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:52 pm

AAPL

DA Davidson analyst Gil Luria has initiated coverage on Apple Inc. (AAPL) with a Neutral rating and set a price target of $166.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:46 pm

FWBI

First Wave BioPharma's stock (FWBI) is trading higher following Roth MKM's decision to maintain a Buy rating and increase the price target from $11 to $40.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:12 pm

UTZ

Needham analyst Matt McGinley initiated coverage on Utz Brands Inc (NYSE:UTZ) with a Buy rating and a $20 price target, adding it to the Needham Conviction List for 2024. McGinley expects Utz to increase its marketing spend by 3x, focusing on four power brands, and to grow sales by 4%-5% annually with a 3-point EBITDA rate improvement over three years. Utz aims for $135 million in cumulative supply chain savings, with internal cost-saving initiatives and supply chain restructuring expected to boost margins and cash flow. Utz trades at a 15x EV/EBITDA multiple, a 2.5 point premium to peers, but is expected to outpace their growth and achieve double the EBITDA growth of peers. The company is transitioning from a regional to a national competitor in the salty snack category, with shares trading higher by 6.11% at $17.37.

Portfolio Pulse from Shivani Kumaresan

January 03, 2024 | 7:03 pm

RNW

Mizuho analyst Maheep Mandloi has reaffirmed a Buy rating on ReNew Energy Global (RNW) and increased the price target from $8 to $10. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 7:02 pm

CHRD

Chord Energy (NASDAQ:CHRD) received mixed analyst ratings with 2 bullish and 3 somewhat bullish over the past three months. The average 12-month price target is $189.8, down from the previous $196.00. Analysts from Mizuho, RBC Capital, Stifel, Piper Sandler, and Wells Fargo provided updates, with price target adjustments reflecting recent market conditions and company performance. Chord Energy's financials show a revenue decline of -5.51% over 3 months, a high net margin of 18.54%, a below-average ROE of 4.27%, an above-average ROA of 3.09%, and a low debt-to-equity ratio of 0.11.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 7:01 pm

SHLS

Shoals Technologies Group Inc (NASDAQ:SHLS) has received 11 analyst ratings in the last three months, with sentiments ranging from bullish to bearish. The average 12-month price target is $24.82, with a high of $33.00 and a low of $17.00, reflecting a 6.09% decrease from the previous average. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Shoals Technologies Gr specializes in EBOS solutions for solar energy projects and has recently entered the electric vehicle charging market. The company's financials show a revenue growth of 47.77% as of September 30, 2023, but it faces challenges with below-average ROE and ROA, despite efficient cost management and a conservative debt approach.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 7:01 pm